Lub hauv paus rau phau ntawv
Tecepeptide yog phau ntawv nyeem phau ntawv tshiab - Muaj cov tshuaj uas tau tshwm sim los ntawm kev kho cov ntshav qab zib ntawm ob hom ntshav qab zib (T2D) thiab rog. Nws yog kev ua lag luam hauv qab cov koom haum hauv qab no xws li Mounjaro (rau cov ntshav qab zib (rau kev tswj hwm qhov hnyav) thiab yog cov neeg nyob hauv Tebchaws Meskas, Tebchaws Asmeskas, Tebchaws Asmeskas, thiab Australia. Kab lus no tham txog nws cov qauv qhia, kev ua tau zoo txuj ci, muab tshuaj, kev nyab xeeb thiab kev txiav txim siab tseem ceeb.
Pom zoo qhia
Thoob ntiaj teb, TirZepatide yog kev pom zoo tshwj xeeb rau:
Mob Ntshav Qab Zib Hom 2: Raws li kev sib tw ua kom muaj kev noj haus thiab kev tawm dag zog txhim kho Glycemic tswj hauv cov neeg laus.
Kev tswj lub cev hnyav: Rau cov neeg laus uas muaj rog (BMI ntau dua lossis sib npaug nrog rau 27) nrog tsawg kawg li-}} paeltension lossis dyslipidemia.
Phiaj los
Cov neeg mob T2D: Tshwj xeeb tshaj yog cov kev tawm tsam nrog qhov hnyav tau txais lossis tsis txaus glycemic tswj ntawm cov kev kho sib txawv.
Kev rog rog / rog dhau los: Nrog rau cov neeg mob ntshav qab zib, tsom mus rau kev poob phaus.
Yam sib pauv
Tirzepatide yog contraindicated hauv:
Cov neeg mob uas muaj tus kheej / tsev neeg cov ntaub ntawv ntawm cov qog nqaij hlav qog nqaij hlav carcinoma (MTC) lossis ntau dua ib endocrine nopprine opprome neophia syndrome hom ob (txiv neej 2).
Cov uas muaj kev cuam tshuam rau kev tu siab lossis nws cov khoom siv.
Cev xeeb tub lossis pub mis niam vim muaj cov ntaub ntawv tiv thaiv.
Secmical Efficacy
Tirzepatide Twin Cov Lus Tawm Zog Grants Cov txiaj ntsig muaj zog:
Glycicic tswj: Hauv kev sim siab loj, nws txo HBA1C nrog kev pabcuam HBA1C nrog kev pabcuam ntawm 1.8-2.6% GLP-1 Agonists zoo li semaglutide.
Lub cev yuag: Qhov poob phaus tau teeb meem ntau dua xya xyoo, dhau los ntawm kev sib txawv ntawm- kev rog.
Koob tshuaj regimen
Rau T2D: pib ntawm 2.5 mg txhua lub hlis, teev lub hlis {}}}}}} mg, lossis 15 mg raws li kev zam rau kev ua siab ntev thiab ua tau zoo.
Rau kev tswj kom hnyav: kev nce qib zoo sib xws, nrog 15 mg ua koob tshuaj Uppeep.
Kev tsis zoo tshwm sim
Cov Txheej Txheem Nrov Cov txiaj ntsig yog cov ris hnyuv thiab koob tshuaj - Nyob:
Xeev siab (12-18%), raws plab (12-16%), ntuav (5-10%).
Me me kom tsim nyog hnyav, tsis tu ncua.
Kev phom sij loj muaj cov pancreatitis, gallbadder kab mob, thiab hypoglycemia (thaum sib xyaw nrog insulin lossis sulfonyhlureas).
Kev Nyab Xeeb Profile
Thaum tirzepatide feem ntau yog zoo -} {}}}} xov tooj lub plab center hauv cov neeg tsis paub meej (pom nyob rau hauv cov kev kawm tsis muaj kev kawm). Kev Saib Xyuas Li Cas
yog tus pab tswv yim rau siab -} txoj kev pheej hmoo ntawm cov neeg mob.
Kev xyiv fab tuaj yeem muab cov ntaub ntawv API nrog rau DMF cov ntaub ntawv, thov koj xav tiv tauj peb rau cov lus (miley921@163.com)
Tag
Tirzepatide redefines remedy paradigms with the aid of addressing each hyperglycemia and obesity, presenting hope for sufferers with T2D and weight-related comorbidities. Nws qhov kev ua tau zoo yog sib npaug nrog kev pab ntawm kev tswj kev tiv thaiv kev tiv thaiv, txawm hais tias qhov kev xaiv tau xaiv tau tus neeg muaj kev cia siab rau tus neeg. Raws li tau saib hloov pauv, tirzepatide yuav ntxiv tawm yog lub pobzeb hauv metabolic muaj mob kev tswj hwm, cov kws kho mob tau muab cov lus qhia txog kev kho mob thiab qhia cov xwm txheej tsis zoo.